2023 - Research.com Chemistry in Norway Leader Award
2022 - Research.com Chemistry in Norway Leader Award
His main research concerns Photodynamic therapy, Photosensitizer, Fluorescence, Biochemistry and Photochemistry. His Photodynamic therapy study combines topics from a wide range of disciplines, such as Molecular biology, Nanotechnology and In vivo. His Photosensitizer research incorporates elements of Ratón, Systemic administration, Hexaminolevulinate and Pathology.
His Fluorescence research integrates issues from Biophysics, Acridine orange, Spectral line, Analytical chemistry and Hematoporphyrin. His Photochemistry study integrates concerns from other disciplines, such as Carcinogenesis, Singlet oxygen, Photosensitivity and Mutagenesis. His Protoporphyrin IX study combines topics in areas such as Dermatology, Human skin, Protoporphyrin and Pharmacology.
His primary areas of study are Photodynamic therapy, Photochemistry, Protoporphyrin IX, Biochemistry and Fluorescence. Johan Emelian Moan has included themes like Cancer research, Pathology, Photosensitizer, Pharmacology and In vivo in his Photodynamic therapy study. His Photochemistry research includes elements of Absorption, Singlet oxygen and Photobleaching.
While the research belongs to areas of Protoporphyrin IX, Johan Emelian Moan spends his time largely on the problem of Human skin, intersecting his research to questions surrounding Erythema and Dermatology. In his study, Cell culture and Fluorescence microscope is strongly linked to Biophysics, which falls under the umbrella field of Biochemistry. His studies deal with areas such as Phthalocyanine and Analytical chemistry as well as Fluorescence.
Vitamin D and neurology, Photodynamic therapy, Dermatology, Internal medicine and Protoporphyrin IX are his primary areas of study. His Vitamin D and neurology research is multidisciplinary, relying on both Body mass index, Cancer, Skin cancer, Vitamin and Physiology. His Photodynamic therapy research is multidisciplinary, incorporating elements of Cancer research, Singlet oxygen, Photosensitizer, Human skin and Pharmacology.
He interconnects Surgery, Epidemiology, Incidence and Melanoma, Cutaneous melanoma in the investigation of issues within Dermatology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Pregnancy, Endocrinology and Oncology. His Protoporphyrin IX course of study focuses on Biochemistry and Clearance rate.
Johan Emelian Moan spends much of his time researching Vitamin D and neurology, Internal medicine, Photodynamic therapy, Endocrinology and Dermatology. His study in Vitamin D and neurology is interdisciplinary in nature, drawing from both Body mass index, Cancer, Vitamin, Sunlight and Animal science. The various areas that he examines in his Photodynamic therapy study include Cancer research, Nanotechnology, Singlet oxygen, Photosensitizer and Human skin.
His work deals with themes such as Inorganic chemistry, Nanoparticle, Fluorescence, Quantum dot and Photochemistry, which intersect with Singlet oxygen. His work on Photosensitizing Agent as part of general Photochemistry study is frequently linked to Photodegradation, therefore connecting diverse disciplines of science. His studies deal with areas such as Protoporphyrin IX and Pharmacology as well as Human skin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Qian Peng;Trond Warloe;Kristian Berg;Johan Moan.
Cancer (1997)
THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN
Johan Moan;Kristian Berg.
Photochemistry and Photobiology (1991)
5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research
Qian Peng;Kristian Berg;Johan Moan;Magne Kongshaug.
Photochemistry and Photobiology (1997)
Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.
Kristian Berg;Pål Kristian Selbo;Lina Prasmickaite;Torunn E. Tjelle.
Cancer Research (1999)
Photochemotherapy of cancer: experimental research.
Johan Moan;Kristian Berg.
Photochemistry and Photobiology (1992)
PORPHYRIN PHOTOSENSITIZATION AND PHOTOTHERAPY
Johan Emelian Moan.
Photochemistry and Photobiology (1986)
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway)
Trude Eid Robsahm;Steinar Tretli;Arne Dahlback;Johan Emelian Moan.
Cancer Causes & Control (2004)
The dependency of vitamin D status on body mass index, gender, age and season
Zoya Lagunova;Alina Carmen Porojnicu;Fedon Lindberg;Sofie Hexeberg.
Anticancer Research (2009)
Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.
Jean Michel Gaullier;Kristian Berg;Qian Peng;Helle Anholt.
Cancer Research (1997)
Milestones in the development of photodynamic therapy and fluorescence diagnosis
Asta Juzeniene;Qian Peng;Johan Emelian Moan;Johan Emelian Moan.
Photochemical and Photobiological Sciences (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Oslo University Hospital
Oslo University Hospital
Oslo University Hospital
Stevens Institute of Technology
Boston University
University of Padua
Norwegian Institute of Public Health
Creighton University
University of Oslo
University of Wisconsin–Madison
Tohoku University
Microsoft (United States)
Argonne National Laboratory
Nara Institute of Science and Technology
Jeonbuk National University
University of Sassari
Agriculture and Agriculture-Food Canada
Texas A&M University
Gifu Pharmaceutical University
University of California, Davis
Institute of Genomics and Integrative Biology
University of Tasmania
University of Arizona
University of Montreal
University of Lausanne
Oregon Research Institute